These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 31085085)
1. The role of the IL-33/ST2 axis in autoimmune disorders: Friend or foe? Liu X; Xiao Y; Pan Y; Li H; Zheng SG; Su W Cytokine Growth Factor Rev; 2019 Dec; 50():60-74. PubMed ID: 31085085 [TBL] [Abstract][Full Text] [Related]
2. The IL-33/ST2 axis is crucial in type 2 airway responses induced by Staphylococcus aureus-derived serine protease-like protein D. Teufelberger AR; Nordengrün M; Braun H; Maes T; De Grove K; Holtappels G; O'Brien C; Provoost S; Hammad H; Gonçalves A; Beyaert R; Declercq W; Vandenabeele P; Krysko DV; Bröker BM; Bachert C; Krysko O J Allergy Clin Immunol; 2018 Feb; 141(2):549-559.e7. PubMed ID: 28532656 [TBL] [Abstract][Full Text] [Related]
3. IL-33 Receptor-Expressing Regulatory T Cells Are Highly Activated, Th2 Biased and Suppress CD4 T Cell Proliferation through IL-10 and TGFβ Release. Siede J; Fröhlich A; Datsi A; Hegazy AN; Varga DV; Holecska V; Saito H; Nakae S; Löhning M PLoS One; 2016; 11(8):e0161507. PubMed ID: 27548066 [TBL] [Abstract][Full Text] [Related]
4. IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases. Vocca L; Di Sano C; Uasuf CG; Sala A; Riccobono L; Gangemi S; Albano GD; Bonanno A; Gagliardo R; Profita M Immunobiology; 2015 Aug; 220(8):954-63. PubMed ID: 25747940 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases. Chen WY; Tsai TH; Yang JL; Li LC Cell Physiol Biochem; 2018; 49(1):349-358. PubMed ID: 30138941 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-33, friend and foe in type-2 immune responses. Hardman C; Ogg G Curr Opin Immunol; 2016 Oct; 42():16-24. PubMed ID: 27254379 [TBL] [Abstract][Full Text] [Related]
7. IL-33/ST2 axis in inflammation and immunopathology. Milovanovic M; Volarevic V; Radosavljevic G; Jovanovic I; Pejnovic N; Arsenijevic N; Lukic ML Immunol Res; 2012 Apr; 52(1-2):89-99. PubMed ID: 22392053 [TBL] [Abstract][Full Text] [Related]
8. Disruption of IL-33 Signaling Limits Early CD8+ T Cell Effector Function Leading to Exhaustion in Murine Hemophagocytic Lymphohistiocytosis. Rood JE; Burn TN; Neal V; Chu N; Behrens EM Front Immunol; 2018; 9():2642. PubMed ID: 30515155 [TBL] [Abstract][Full Text] [Related]
9. ST2 deletion increases inflammatory bone destruction in experimentally induced periapical lesions in mice. Velickovic M; Pejnovic N; Mitrovic S; Radosavljevic G; Jovanovic I; Kanjevac T; Jovicic N; Lukic A J Endod; 2015 Mar; 41(3):369-75. PubMed ID: 25595464 [TBL] [Abstract][Full Text] [Related]
10. Mast cells are essential intermediaries in regulating IL-33/ST2 signaling for an immune network favorable to mucosal healing in experimentally inflamed colons. He Z; Song J; Hua J; Yang M; Ma Y; Yu T; Feng J; Liu B; Wang X; Li Y; Li J Cell Death Dis; 2018 Dec; 9(12):1173. PubMed ID: 30518915 [TBL] [Abstract][Full Text] [Related]
11. IL-33/ST2 Axis Plays a Protective Effect in Kuo CF; Chen WY; Yu HH; Tsai YH; Chang YC; Chang CP; Tsao N Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638904 [TBL] [Abstract][Full Text] [Related]
12. Detrimental role of IL-33/ST2 pathway sustaining a chronic eosinophil-dependent Th2 inflammatory response, tissue damage and parasite burden during Toxocara canis infection in mice. Leal-Silva T; Vieira-Santos F; Oliveira FMS; Padrão LLS; Kraemer L; da Paixão Matias PH; de Almeida Lopes C; Loiola Ruas AC; de Azevedo IC; Nogueira DS; Rachid MA; Caliari MV; Castro Russo R; Fujiwara RT; Bueno LL PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009639. PubMed ID: 34324507 [TBL] [Abstract][Full Text] [Related]
13. IL-33 induces both regulatory B cells and regulatory T cells in dextran sulfate sodium-induced colitis. Zhu J; Xu Y; Zhu C; Zhao J; Meng X; Chen S; Wang T; Li X; Zhang L; Lu C; Liu H; Sun X Int Immunopharmacol; 2017 May; 46():38-47. PubMed ID: 28258042 [TBL] [Abstract][Full Text] [Related]
14. The Role of the IL-33/ST2 Immune Pathway in Autoimmunity: New Insights and Perspectives. Ramezani F; Babaie F; Aslani S; Hemmatzadeh M; Mohammadi FS; Gowhari-Shabgah A; Jadidi-Niaragh F; Ezzatifar F; Mohammadi H Immunol Invest; 2022 May; 51(4):1060-1086. PubMed ID: 33522348 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-33 and ST2 Signaling in Tumor Microenvironment. Hong J; Kim S; Lin PC J Interferon Cytokine Res; 2019 Jan; 39(1):61-71. PubMed ID: 30256696 [TBL] [Abstract][Full Text] [Related]
17. The IL-33/ST2 axis: Role in health and disease. De la Fuente M; MacDonald TT; Hermoso MA Cytokine Growth Factor Rev; 2015 Dec; 26(6):615-23. PubMed ID: 26271893 [TBL] [Abstract][Full Text] [Related]
18. IL-33/ST2 axis in autoimmune disease. Shakerian L; Kolahdooz H; Garousi M; Keyvani V; Kamal Kheder R; Abdulsattar Faraj T; Yazdanpanah E; Esmaeili SA Cytokine; 2022 Oct; 158():156015. PubMed ID: 36041312 [TBL] [Abstract][Full Text] [Related]
19. IL-33 Receptor (ST2) Signalling is Important for Regulation of Th2-Mediated Airway Inflammation in a Murine Model of Acute Respiratory Syncytial Virus Infection. Zeng S; Wu J; Liu J; Qi F; Liu B Scand J Immunol; 2015 Jun; 81(6):494-501. PubMed ID: 25721734 [TBL] [Abstract][Full Text] [Related]
20. A cellular and molecular view of T helper 17 cell plasticity in autoimmunity. Stadhouders R; Lubberts E; Hendriks RW J Autoimmun; 2018 Feb; 87():1-15. PubMed ID: 29275836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]